HyalDew Clinical Formulations
Composition Parameters
HA Concentration: 20.0 mg/mL
Lidocaine HCl: 0.3%
Endotoxin: ≤ 0.1 EU/mL
pH Level: 6.8 – 7.5
MCL Rheological Data
Particle Range: 300-600μm
Viscoelasticity (G’/G”): 2:1
Swelling Propensity: Low
Degradation Cycle: 12-18 Months
Targeted Viscosity Grading
Indication: Superficial dermis
: 30G x 13mm
Technique: Mesotherapy
Indication: Mid dermis
: 27G x 13mm
Technique: Linear threading
Indication: Deep dermis
: 27G x 13mm
Technique: Cross-hatching
Indication: Subcutaneous
: 25G x 13mm /
Technique: Bolus / Fanning
Regulatory Compliance
Manufacturer: BioPlus Co., Ltd.
Kinternational registration: No. 3A21765
Quality System:
Packaging: 1.0mL Sterile x 1
Storage Condition: 2°C – 25°C (Avoid direct sunlight)
Shelf Life: 24 months
Medical Warnings & Restrictions
For licensed medical practitioners only.
Contraindications: Patients with known hypersensitivity to hyaluronic acid, lidocaine sensitivity, history of severe allergies/anaphylaxis, bleeding disorders, or active skin inflammation/infection at the injection site.
Adverse Reactions: Erythema, swelling, pain, itching, bruising, or tenderness at the implant site. Typically resolves within 72 hours.


Reviews
There are no reviews yet.